Q
Quince Therapeutics, Inc. (QNCX)
NMS – Real vaqt narxi. Valyuta: USD
1.26
+0.02 (1.61%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.23
-0.03 (-2.38%)
Bozor oldidan: May 13, 2026, 5:46 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
1.26
+0.02 (1.61%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.23
-0.03 (-2.38%)
Bozor oldidan: May 13, 2026, 5:46 AM EDT
Quince Therapeutics, Inc., bir biofarmatsevtika kompaniyasi, nogiron qiluvchi va kam uchraydigan kasalliklarga chalingan bemorlar uchun terapevtik vositalarni sotib olish, rivojlantirish va tijoratlashtirishga qaratilgan. Kompaniyaning asosiy dorivor nomzodi kam uchraydigan pediatrik neyrodegenerativ kasallikni, shu jumladan ATM genidagi mutatsiyalar tufayli yuzaga keladigan irsiy autosomal-resessiv neyrodegenerativ va immunitet tanqisligi bo'lgan A-T ni davolash uchun EryDexni o'z ichiga oladi. Uning AIDE texnologik platformasi, bemorning o'z qizil qon hujayralariga dori vositasini kapsulalash uchun avtomatlashtirilgan jarayondan foydalanadigan dori/qurilma kombinatsiyasi platformasi, shuningdek, avtomatlashtirilgan uskunalar RCL, tibbiy asboblar, shprits to'plami va texnologik eritmalardan iborat bo'lgan to'plamni o'z ichiga oladi. Kompaniya ilgari Cortexyme, Inc. nomi bilan tanilgan va 2022 yil avgust oyida Quince Therapeutics, Inc. nomini o'zgartirgan. Kompaniya 2012 yilda tashkil etilgan va shtab-kvartirasi Janubiy San-Frantsisko, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Charles S. Ryan J.D., Ph.D. | President |
| Dr. Dirk Thye M.D. | CEO, Chief Medical Officer & Director |
| Dr. Guenter R. Janhofer M.D., Ph.D. | Chief Scientific Officer |
| Mr. Brendan Hannah M.B.A. | Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer |
| Mr. Giovanni Mambrini M.Sc. | Chief Technology Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-28 | 8-K | d623526d8k.htm |
| 2026-04-27 | DEFA14A | qncx-20260424.htm |
| 2026-04-27 | DEF 14A | qncx-20260424.htm |
| 2026-04-22 | 8-K | d27180d8k.htm |
| 2026-04-17 | S-8 | d117236ds8.htm |
| 2026-04-17 | PRE 14A | qncx-20260417.htm |
| 2026-04-10 | 10-K | qncx-20251231.htm |
| 2026-04-09 | 8-K | d115661d8k.htm |
| 2026-04-01 | NT 10-K | d140699dnt10k.htm |
| 2026-03-30 | 8-K | d57124d8k.htm |